atai Life Sciences (ATAI) Misses Q2 EPS by 2c

atai Life Sciences (NASDAQ: ATAI) reported Q2 EPS of ($0.14), $0.02 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $720 thousand.

For earnings history and earnings-related data on atai Life Sciences (ATAI) click here.

You May Also Be Interested In

• Trump on Iran: we're trying to work out a deal that's fair
• Walmart to pay $1.4 billion for Vibe.co acquisition - WSJ
• Wealthfront launches custodial account with tax-gain harvesting